Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
American Heart Association (AHA)
Adjustments are often made based on both lab results and your symptoms
They respond in less than 24 hours
FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, FDA (2024) FDA drug shortages, FDA (2024) Hikma receives FDA approval and launches the generic version of Victoza, Liraglutide, in the U.S., Hikma (2024) How Victoza works, Novo Nordisk Liraglutide injection, MedLinePlus (2021) Special report: Potential strategies for addressing GLP-1 and dual GLP-1/GIP receptor agonist shortages, Clinical Diabetes (2023) Type 2 diabetes, CDC (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
US$ 29.85
US$ 24.51
US$ 25.38
US$ 24.00
US$ 25.98
US$ 23.13
US$ 25.61
US$ 21.06
US$ 28.05
